Clinical trial
A Multicenter, Multi-Cohort, Phase II Study of Sacituzumab Tirumotecan With or Without Tislelizumab in Patients With Advanced Thyroid Cancer
NCT07068542 is registered in ClinicalTrials.gov with Zhejiang Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Multi-Cohort, Phase II Study of Sacituzumab Tirumotecan With or Without Tislelizumab in Patients With Advanced Thyroid Cancer
- Lead sponsor
- Zhejiang Provincial People's Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 1, 2025
- Completion date
- December 31, 2028
- Enrollment
- 94 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced thyroid carcinoma, poorly differentiated thyroid carcinoma, radioiodine-refractory differentiated thyroid cancer